Trials / Not Yet Recruiting
Not Yet RecruitingNCT06618547
Effectiveness and Safety of the TENEO 317 Model 2 Excimer Laser to Treat Myopia With or Without Astigmatism by Transepithelial Photorefractive Keratectomy
A Study to Investigate the Effectiveness and Safety of the TENEO 317 Model 2 Excimer Laser to Treat Myopia With or Without Astigmatism by Transepithelial Photorefractive Keratectomy
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 140 (estimated)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
A Study to Investigate the Effectiveness and Safety of the TENEO 317 Model 2 Excimer Laser to Treat Myopia with or without Astigmatism by Transepithelial Photorefractive Keratectomy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TENEO 317 Model 2 excimer laser | TENEO 317 Model 2 excimer laser by Transepithelial Photorefractive Keratectomy |
Timeline
- Start date
- 2025-11-01
- Primary completion
- 2026-11-01
- Completion
- 2026-11-01
- First posted
- 2024-10-01
- Last updated
- 2025-06-15
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06618547. Inclusion in this directory is not an endorsement.